Share on Pinterest An experimental CRISPR-based gene editing treatment significantly improved vision outcomes in subjects with a rare eye disorder. Robert Nickelsberg/Getty Images Researchers from ...

A Johnson & Johnson gene therapy in development for an inherited vision-loss disorder has failed a Phase 3 study, the latest clinical research setback for a rare eye disease that so far has no ...

Stargardt programs address ABCA4 payload constraints via dual-AAV platforms (VG801, AAVB-039) and explore first ...

Binocular vision disorders encompass a range of conditions that impair the coordinated function of the eyes, detrimentally affecting the ability to focus, process depth and maintain visual comfort.

In the "ThemenCheck Medizin" procedure offered by the German Institute for Quality and Efficiency in Health Care (IQWiG), interested members of the public can submit proposals for the assessment of ...

For her entire life, college student Olivia Cook had only a small degree of central vision. It was as if she was watching the world through a straw hole, and in dimly lit places, she could not make ...

FDA authorization under an IND permits first-in-human phase I/II testing of SVT-001 in familial drusen, focusing on safety ...

A revolutionary gene therapy treatment in London has improved the vision of children suffering from a rare genetic disorder, offering hope to families worldwide. Among the first to benefit from the ...

Light sensitivity in one eye could occur for many reasons, ranging from minor injuries, dry eye, and migraine to more serious conditions, such as multiple sclerosis. Light sensitivity, or photophobia, ...

Semaglutide showed no significant association with increased risk of eye disorders or diabetic retinopathy in the meta-analysis. A potential link between semaglutide and increased risk of NAION was ...

Little Harvey Haines has been given a new lease of life. Born with a rare eye condition severely affecting his sight, he struggled to communicate with children his own age, shied away from ...